Animal and cell culture studies further support a role for the GH/ insulin-like growth factor-1 (IGF-1) axis in the pathophysiology of NAFLD and its progression to NASH and fibrosis [11]. The gene discussed is GH1; the disease is metabolic dysfunction-associated steatotic liver disease.